Acellular mucin in neoplastic and non-neoplastic conditions of the lower gastrointestinal tract
Related Experiment Video
Updated: Sep 13, 2025

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
Noureldien Darwish1, Lynn Guo1, Eundong Park1
1Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, United States.
Abstract:
Acellular mucin refers to pools of mucin without epithelial component, oftentimes harboring inflammatory cells. Acellular mucin can be observed in both neoplastic and non-neoplastic lower gastrointestinal (GI) conditions. While mucinous neoplasms are classified and staged using established guidelines, interobserver variability occurs when acellular mucin pools are encountered, leading to inconsistent interpretation and staging. In particular, acellular mucin found in regional lymph nodes of colorectal adenocarcinoma patients who have not received treatment presents a diagnostic challenge, as its prognostic implication is not clearly defined. Acellular mucin is also commonly seen in treated colorectal adenocarcinoma, post neoadjuvant therapy. Although acellular mucin is not counted toward T or N staging in this setting, variation in how pathologists report and stage these cases persists. Acellular mucin can also be seen in non-neoplastic specimens, such as those from interval appendectomies, appendiceal diverticula, colonic diverticulitis, volvulus, and Crohn's disease where it may mimic a neoplastic lesion. Acellular mucin in this setting is often a byproduct of inflammation, increased luminal pressure, and mural defect. This review highlights the clinical relevance and diagnostic complexity of acellular mucin in pathologic conditions of the lower GI tract. Further studies are needed to clarify its prognostic value and develop standardized guidelines.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
08:51Profiling of Permethylated Mucin O-glycans Using Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry
Published on: June 20, 2025
Related Concept Videos
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Histology of the Gastrointestinal (GI) Tract
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.